Delta 9 Cannabis (CVE:NINE) Trading 3% Higher – Should You Buy?

Delta 9 Cannabis Inc (CVE:NINEGet Free Report)’s share price shot up 3% during mid-day trading on Tuesday . The stock traded as high as C$1.13 and last traded at C$1.03. 68,728 shares traded hands during trading, a decline of 41% from the average session volume of 117,300 shares. The stock had previously closed at C$1.00.

Delta 9 Cannabis Price Performance

The company has a debt-to-equity ratio of 33.00, a quick ratio of 2.04 and a current ratio of 4.44. The company has a market capitalization of C$89.36 million and a PE ratio of 19.07. The company’s 50-day simple moving average is C$1.03 and its 200-day simple moving average is C$1.03.

About Delta 9 Cannabis

(Get Free Report)

Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers.

Further Reading

Receive News & Ratings for Delta 9 Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delta 9 Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.